Informed consent requires that research participants understand the study under consideration and appreciate its implications for their interests. Therapeutic misconception – which occurs when individuals confuse the purposes of clinical research with standard clinical care – compromises informed consent. Dr. Bryan A. Sisk expanded the discussions beyond therapeutic misconception in clinical trials by explaining multiple ways in which understanding and appreciation of information about a clinical trial can be undermined. He offered a framework of therapeutic misperceptions to assist researchers in managing challenges to the informed consent process.
This activity was designed for physicians and other healthcare professionals. By the end of this talk, attendees were able to do the following:
- Identify two components of decisional capacity
- Discuss challenges of therapeutic misperceptions in the clinic-research setting
- Explore a framework of therapeutic misperceptions
Bryan A. Sisk, MD, MSCI, focuses on identifying, measuring, and intervening upon communication functions in pediatric oncology and palliative care. He is especially interested in the social and ethical issues related to the child-parent-clinician relationship when children have serious illnesses.